Related Experiment Videos
Isolation of human complement factors C3, C5 and H.
Journal of Immunological Methods
|July 16, 1985
Summary
This study presents an improved method for purifying complement factors C3, C5, and H from human plasma. The new technique efficiently isolates these crucial proteins for further research and therapeutic applications.
Area of Science:
- Biochemistry
- Immunology
- Protein Chemistry
Background:
- Complement factors C3, C5, and H are critical components of the human immune system.
- Efficient and simultaneous purification of these factors is essential for research and potential therapeutic applications.
- Existing purification methods may lack efficiency or the ability to isolate multiple factors concurrently.
Purpose of the Study:
- To develop an improved, simultaneous purification method for complement factors C3, C5, and H from human plasma.
- To achieve high purity and yield of the target complement factors.
- To establish a robust protocol for researchers and clinicians.
Main Methods:
- Utilized QAE-Sephadex batch separation followed by SP-Sephadex chromatography and Sephadex G-200 gel filtration for initial purification.
- Employed DEAE-Sephacel chromatography for simultaneous isolation of factors H and C5 from post-SP-Sephadex material.
- Incorporated anti-C3-Sepharose affinity chromatography to remove residual C3 from the C5 pool.
- Applied maleylation or citraconylation of reduced and alkylated C3 to enable separation of its polypeptide chains via ion exchange chromatography.
Main Results:
- Successfully purified 600 mg of highly pure C3 from 1600 ml of human plasma.
- Simultaneously obtained approximately 70 mg of highly pure factor H and 30 mg of highly pure C5.
- Demonstrated effective removal of C3 contamination from the C5 fraction using specific affinity chromatography.
- Showcased the ability to separate C3 polypeptide chains after chemical modification.
Conclusions:
- The developed method offers an efficient and simultaneous approach for purifying complement factors C3, C5, and H.
- This protocol yields high-purity proteins, suitable for various research and clinical applications.
- The modification of C3 polypeptide chains provides a novel strategy for further fractionation and analysis.